Axalta has remained at the forefront of the coatings industry by continually investing in innovative solutions. We engineer technologies that protect customers’ products—whether against heat, light, corrosion, abrasion, moisture, or chemicals—and add dimension and beauty with
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio
Axalta has remained at the forefront of the coatings industry by continually investing in innovative solutions. We engineer technologies that protect customers’ products—whether against heat, light, corrosion, abrasion, moisture, or chemicals—and add dimension and beauty with
Axalta has remained at the forefront of the coatings industry by continually investing in innovative solutions. We engineer technologies that protect customers’ products—whether against heat, light, corrosion, abrasion, moisture, or chemicals—and add dimension and beauty with